亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Change and Recovery of Choroid Thickness after Short-term Application of 1% Atropine Gel and Its Influencing Factors in 6-7-year-old Children

阿托品 脉络膜 期限(时间) 眼科 医学 儿科 麻醉 心理学 视网膜 神经科学 物理 量子力学
作者
Yunjia Jiang,Zhengwei Zhang,Zhifeng Wu,Song Yung Sun,Yuting Fu,Bilian Ke
出处
期刊:Current Eye Research [Taylor & Francis]
卷期号:46 (8): 1171-1177 被引量:20
标识
DOI:10.1080/02713683.2020.1863431
摘要

To investigate the change and recovery of choroid thickness after short-term application of 1% atropine gel and its influencing factors in 6-7-year-old children.71 right eyes of 71 children were enrolled and divided into myopia and control group. 1% atropine gel was administered twice a day for one week and then stopped. Spherical equivalent (SE), accommodative amplitude (AA), keratometry (K), axial length (AL), and choroidal thickness (CT) were obtained at baseline and 1st, 4th, and 8th weeks. CT was measured at subfovea and 1 mm, 2 mm, and 3 mm temporal, superior, nasal, and inferior from the fovea using spectral-domain optical coherence tomography.In both groups, all CTs increased following the change in SE, AA, and AL after administration of 1% atropine for one week. They gradually recovered to baseline levels seven weeks after withdrawal. The change (Δ) in CT at 3 mm superior from the fovea was significantly higher in the myopia group than in the control group. In both groups, ΔCT at subfovea had no significant correlation with SE, AA, and AL, both at baseline and one week. However, ΔCT at subfovea was negatively correlated with ΔAL in the control group.One-week application of 1% atropine gel may increase CT in 6-7-year-old Chinese children. Meanwhile, the recovery process after withdrawal lasts seven weeks. During the recovery process, the changes in structural parameters (AL, CT) and functional parameters (AA, SE) in both groups occurred synchronously. The SE, AA, and AL at baseline may not predict the extent of atropine's effect on CT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
32秒前
pete发布了新的文献求助10
39秒前
pete驳回了传奇3应助
51秒前
风中的迎丝完成签到,获得积分10
1分钟前
知行者完成签到 ,获得积分10
1分钟前
刻苦羽毛完成签到 ,获得积分10
1分钟前
haralee完成签到 ,获得积分10
3分钟前
3分钟前
Su完成签到 ,获得积分10
3分钟前
xiaoder发布了新的文献求助10
3分钟前
z脏脏包完成签到 ,获得积分10
3分钟前
3分钟前
2025211022完成签到,获得积分20
3分钟前
2025211022发布了新的文献求助10
4分钟前
4分钟前
科研通AI2S应助科研通管家采纳,获得10
5分钟前
5分钟前
村口的帅老头完成签到 ,获得积分0
5分钟前
科研通AI6.1应助houyuhao123123采纳,获得30
5分钟前
ffff完成签到 ,获得积分10
5分钟前
6分钟前
6分钟前
6分钟前
6分钟前
ZZZ发布了新的文献求助10
7分钟前
ZZZ完成签到,获得积分10
7分钟前
卤肉饭与石榴汁完成签到,获得积分10
7分钟前
meeteryu完成签到,获得积分10
7分钟前
7分钟前
pete完成签到,获得积分10
7分钟前
George完成签到,获得积分10
8分钟前
江水边完成签到 ,获得积分10
8分钟前
9分钟前
9分钟前
科研通AI6.2应助ben采纳,获得10
10分钟前
10分钟前
ben发布了新的文献求助10
10分钟前
Abdurrahman完成签到,获得积分10
10分钟前
10分钟前
大模型应助科研通管家采纳,获得10
11分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6947951
求助须知:如何正确求助?哪些是违规求助? 8632781
关于积分的说明 18307715
捐赠科研通 6386557
什么是DOI,文献DOI怎么找? 3080694
关于科研通互助平台的介绍 2123694
邀请新用户注册赠送积分活动 2057586